A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma Phase 1 study results of Cis-UCA Eye Drops published

Herantis Pharma Phase 1 study results of Cis-UCA Eye Drops published Herantis Pharma Plc. Company release 26 January 2015 at…

Read More

Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops in Patients with Dry Eye Syndrome, results expected in Q3/2015

Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops in Patients with Dry Eye Syndrome, results expected in…

Read More

Herantis Pharma Plc's financial reporting in 2015

Herantis Pharma Plc's financial reporting in 2015 Herantis Pharma Plc. Company release 18 December 2014 at 10:00 am Herantis Pharma…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.